2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other
2
Head & Neck
2
Conditions
Lymphoma
3
Stomatitis
2
Small Cell Lung Carcinoma
2
Neoplasms
2
Mucositis
2
Mouth Neoplasms
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Small Cell
2
Brain Neoplasms
2
Spinal Cord Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Low-Level Light Therapy
14
Fibroblast Growth Factor 7
10
Cisplatin
6
Standard of Care
5
avasopasem manganese
4
Radiotherapy, Intensity-Modulated
4
Propolis
4
Mouthwashes
4
Cryotherapy
4
Water
3
Sodium Bicarbonate
3
Saline Solution
3
Radiotherapy
3
Laser Therapy
3
Injections
3
Drug Therapy
3
Control Groups
3
Benzydamine
3
golotimod
2
aluminum hydroxide, magnesium hydroxide, drug combination
2
Xylitol
2
Vitamin E
2
Vitamin B 12
2
Sodium Chloride
2
Saliva, Artificial
2
RRx-001
2
Practice Guidelines as Topic
2
Lidocaine
2
Honey
2
Glutamine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Stomatitis
×
RRx-001
×
Clear all
NCT05966194
2024-11-15
KEVLARx
EpicentRx, Inc.
Phase 2
Recruiting
216 enrolled
NCT03515538
2024-11-04
PREVLAR
EpicentRx, Inc.
Phase 2
Completed
53 enrolled
15 charts